Identification of disulfidptosis in esophageal squamous cell carcinoma based on single-cell and bulk RNA-seq data to predict prognosis and treatment response
This study provides a new prognostic signature for ESCC, explores new therapeutic targets, and provides new theoretical support for personalized treatment.
Authors
- Xiao Lin (ORCID: https://orcid.org/0000-0002-3848-0244)
- Jianting Du (ORCID: https://orcid.org/0000-0002-5431-4668)
- Maohui Chen (ORCID: https://orcid.org/0000-0001-6931-8875)
- Taidui Zeng (ORCID: https://orcid.org/0000-0001-8602-8909)
- Xiaodan Zhang (ORCID: https://orcid.org/0000-0002-7809-8496)
- Chun Chen (ORCID: https://orcid.org/0000-0001-9264-8020)
- Bin Zheng (ORCID: https://orcid.org/0000-0001-8429-5384)
- Shuliang Zhang (ORCID: https://orcid.org/0000-0003-2320-7912)
- Guanglei Huang
Institutions
- Fujian Medical University (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.3389/fimmu.2025.1567793
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00